1. Improvement of endothelial dysfunction as a surrogate endpoint in the treatment of hypertension

   • Teguh Santoso

   Invited Commentary Pages: 227 - 229

2. Web alert

   News Pages: 230 - 231

3. Literature alert

   Abstract Pages: 232 - 235

4. Review of recent framingham study hypertension research

   • William B. Kannel

   Clinical Trials Review Pages: 239 - 240

5. Doxazosin arm of the ALLHAT study discontinued: How equal are antihypertensive drugs?

   • Franz H. Messerli
   • Ehud Grossman

   Clinical Trials Review Pages: 241 - 242

6. Joint national committee VI: Individualized versus indiscriminate therapy for hypertension

   • Charles P. Tifft

   OriginalPaper Pages: 243 - 246

7. The influence of national guidelines on antihypertensive prescribing patterns

   • David Siegel

   OriginalPaper Pages: 247 - 252

8. Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance?

   • Stanley S. Franklin

   OriginalPaper Pages: 253 - 259

9. Optimal antihypertensive therapy for prevention and treatment of left ventricular hypertrophy

   • Philip R. Liebson
   • Rod D. Serry

   OriginalPaper Pages: 260 - 270

10. Diastolic pressure, systolic pressure, or pulse pressure?

    • Charalambos Vlachopoulos
    • Michael O’Rourke

    OriginalPaper Pages: 271 - 279

11. Effects of antihypertensive therapy on hypertensive vascular disease

    • Jong Bae Park
    • Ernesto L. Schiffrin

    OriginalPaper Pages: 280 - 288

12. Antihypertensive drug therapy in the third millennium: Are there benefits beyond blood pressure?

    • Stephen E. Bakir
    • Suzanne Oparil

    Clinical Trials Review Pages: 291 - 294

13. Aldosterone-related genetic effects in hypertension

    • David G. Warnock

    OriginalPaper Pages: 295 - 301

14. Central nervous system norepinephrine metabolism in hypertension

    • Gavin W. Lambert

    OriginalPaper Pages: 302 - 310

15. Interaction between leptin and sympathetic nervous system in hypertension

    • William G. Haynes

    OriginalPaper Pages: 311 - 318

16. Role of the sympathetic nervous system in human renovascular hypertension

    • Mats Johansson
    • Peter Friberg

    OriginalPaper Pages: 319 - 326

17. Aldosterone and vascular damage

    • Daniel Duprez
    • Marc De Buyzere
    • Denis L. Clement

    OriginalPaper Pages: 327 - 334

18. Treatment of hypertension in diabetes mellitus

    • Alejandro de la Sierra
    • Luis Miguel Ruilope

    OriginalPaper Pages: 335 - 342